Table 1.
Baseline characteristics and risk factors of pulmonary co-infection.
| Fungal and bacterial co-infection | Fungal infection | Univariable OR a (95% CI b ) | P value | Multivariable OR (95% CI) | P value | |
|---|---|---|---|---|---|---|
| Age (years) | 43.04 ± 18.2 | 40.77 ± 18.8 | – | 0.580 | – | – |
| Sex | ||||||
| Male | 32 (66.7%) | 40 (56.3%) | 1.55 (0.72–3.32) |
0.258 | – | – |
| Female | 16 (33.3%) | 31 (43.7%) | ||||
| Immune function | ||||||
| Normal | 5 (10.4%) | 18 (25.4%) | 2.92 (1.00–8.51) |
0.043 | 3.20 (1.07–9.62) |
0.038 |
| Defective | 43 (89.6%) | 53 (74.6%) | ||||
| Antibacterial treatment | 31 (64.6%) | 48 (67.6%) | 0.874 (0.40–1.89) |
0.732 | – | – |
| CT image manifestation (Cavity lesions) |
13 (27%) | 9 (12.7%) | 2.56 (0.99–6.59) |
0.047 | 2.81 (1.06–7.49) |
0.039 |
| Isolated viruses | 10 (20.8%) | 11 (15.5%) | – | 0.453 | – | – |
| Fungus species | ||||||
| Aspergillus | 21 (43.8%) | 26 (36.6%) | – | 0.591 c | – | – |
| Pneumocystis | 11 (22.9%) | 19 (26.8%) | ||||
| Rhizopus | 9 (18.8%) | 12 (16.9%) | ||||
| Cryptococcus | 3 (6.3%) | 8 (11.3) | ||||
| Lichtheimia | 2 (4.2%) | 3 (4.2%) | ||||
| Penicillium | 1 (2%) | 2 (2.8%) | ||||
| Mucor | 1 (2%) | 0 (0%) | ||||
| Scedosporium | 0 (0%) | 1 (1.4%) |
a
OR, odds ratio.
b
CI, confidence interval.
c
Calculated by t-test.